Assessment of the American Joint Committee on Cancer (6th and 7th editions) for clinically localized prostate cancer and comparison to the National Comprehensive Cancer Network risk stratification method.


23 Background: The purpose was to compare the prognostic value of the AJCC staging version 6 (v6), version 7 (v7), and the risk-stratification model of the NCCN. METHODS 2,469 men (1989-2006) with clinical T1-4, N0/X-N1, M0 prostate cancer received definitive RT +/- ADT (median follow-up: 70 months). The NCCN grouping was: low-risk included T1-T2a, GS < 7… (More)
DOI: 10.1200/jco.2012.30.5_suppl.23